Greg Chifulini

VP, Finance, US Market & Alliances at Genmab

Speaker

Greg Chifulini is Vice President of Finance for US Market and Alliances at Genmab, a leading international biotechnology company specializing in the development of innovative antibody therapeutics. In this role, Greg oversees financial strategy and operations for the US business, driving sustainable growth and providing strategic financial partnership to the organization’s leadership. A key achievement in his role has been leading the comprehensive build-out of finance capabilities and shaping the business strategy to support Genmab’s first-ever commercial launch.

With over 20 years of progressive experience in finance, Greg brings a wealth of knowledge and a results-driven approach to his leadership. Prior to joining Genmab, he held a variety of finance roles at Johnson & Johnson, one of the world's largest healthcare companies. Throughout his tenure at J&J, Greg gained extensive experience across multiple sectors, including pharmaceuticals and consumer products. His roles spanned financial planning, analysis, and strategy, where he consistently demonstrated his ability to lead teams, manage complex budgets, and align financial initiatives with overarching business goals.

In his last role at Johnson & Johnson, Greg served as the leader for Strategic Pricing in Solid Tumor Oncology. In this capacity, he was responsible for developing and executing pricing strategies that maximized product value while ensuring patient access. His work required close collaboration with cross-functional teams, including marketing, market access, BI&A and regulatory affairs, to navigate the complexities of oncology markets and contribute to J&J’s success in this critical therapeutic area.

Greg’s extensive background equips him with a deep understanding of the intersection between finance and business strategy, allowing him to navigate challenges and seize opportunities in the highly regulated and fast-paced healthcare industry.